Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study.

Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study.

Item
http://www.wikidata.org/entity/Q41034752
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemiaPost-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation.The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography.Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.Population pharmacokinetics of thrombomodulin alfa in pediatric patients with hematological malignancy and disseminated intravascular coagulation.Observational study to compare antithrombin and thrombomodulin for disseminated intravascular coagulation.Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.The recent time trend of outcomes of disseminated intravascular coagulation in Japan: an observational study based on a national administrative database.Thrombomodulin is a Strong Predictor of Multiorgan Dysfunction Syndrome in Patients With Sepsis.Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.Efficacy evaluation of D-dimer and modified criteria in overt and nonovert disseminated intravascular coagulation diagnosis.Efficacy of recombinant human soluble thrombomodulin for childhood hemolytic uremic syndrome.
P2860

Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study.

Item
http://www.wikidata.org/entity/Q41034752
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Recombinant human soluble thro ...... a retrospective cohort study.
@en
type
label
Recombinant human soluble thro ...... a retrospective cohort study.
@en
prefLabel
Recombinant human soluble thro ...... a retrospective cohort study.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Recombinant human soluble thro ...... a retrospective cohort study.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932